The NIH genetic testing registry: Hereditary, pharmacogenetic, and somatic tests for oncology practice.

11104 Background: Oncology professionals need to access and gauge information about tests for hereditary cancer predisposition, biomarkers, pharmacogenetic dosing and risk-based chemoprevention. NIH has created the Genetic Testing Registry (GTR; http://www.ncbi.nlm.nih.gov/gtr/), a freely available, web-based resource to enable centralized access to comprehensive information about genetic tests and improve transparency. Methods: GTR was implemented by the National Center for Biotechnology Information (NCBI) with oversight by the NIH Office of the Director, extensive input from diverse stakeholders, and ongoing consultation with two advisory committees and other Federal agencies. Data are voluntarily submitted by laboratory providers (e.g., indications, methods, targets, FDA review status, CPT molecular pathology codes) and supplemented by NCBI (e.g., practice guidelines and informative web links to molecular, literature and other resources). Results: As of February 2014, GTR has 13,878 registered tests fo...